Share this page on LinkedIn
Share This Page on Google+
Share This Page on Twitter
tell someone about this page print this page
You are here: Contents > 2017 > Volume 26 Number 3 May 2017 > AORTIC VALVE DISEASE > TAVI for Failed Valve-Sparing Operations: In-Hospital and Mid-Term Outcome

TAVI for Failed Valve-Sparing Operations: In-Hospital and Mid-Term Outcome

Francesco Notaristefano1,4, Salvatore Notaristefano2, Rocco Sclafani2, Matteo R. Reccia1, Roberto Annunziata1, Uberto Da Col3, Giuseppe Ambrosio1, Claudio Cavallini2

1Cardiovascular Pathology and Pathophysiology Department, University Hospital of Perugia, Italy
2Cardiology Department, University Hospital of Perugia, Italy
3Cardiac Surgery Department, University Hospital of Perugia, Italy
4Electronic correspondence: not.francesco@gmail.com

Background and aim of the study: Although transcatheter aortic valve implantation (TAVI) is a steadily expanding treatment for the pathology of the aortic valve, its role in the replacement of native aortic valves following valve-sparing surgery has not been investigated.

Methods: Among 150 patients who underwent TAVI at the authors’ institution, three (2%) had a failed valve-sparing operation. The in-hospital outcome, mid-term mortality, and valvular function of the three patients were evaluated retrospectively. These patients, who were deemed at high surgical risk by the heart team, underwent TAVI for predominant severe aortic stenosis (n = 2) or pure severe aortic regurgitation (AR) (n = 1).

Results: A self-expandable CoreValve prosthesis was inserted via femoral access in all three patients. Based on


the Valve Academic Research Consortium 2 criteria (VARC-2), implantation was successful in all cases, with only one major access site complication and no more than mild residual AR. At a follow up of 13 ± 6 months there were no deaths and the mean transvalvular gradient remained low (7 ± 6 mmHg at discharge; 7 ± 4 mmHg at follow up), without any echocardiographic signs of valve deterioration.

Conclusion: The results obtained with this small patient cohort demonstrated the feasibility, safety, and favorable mid-term outcomes of TAVI for failed valve-sparing operations in high surgical risk patients. However, these findings must be validated in larger cohorts before extending such treatment routinely to this subset of patients.

The Journal of Heart Valve Disease 2017;26:268-273


TAVI for Failed Valve-Sparing Operations: In-Hospital and Mid-Term Outcome

Click the above hyperlink to view the article, right click (Ctrl click on a Mac) to open in a new browser window or tab.

Purchase this Article

Please click the button below to purchase this article. Single article purchases are provided at $50.00 per article. Upon clicking the button below, single article user account subscription details are requested and, upon successful payment, a single article user account is created. Single articles are availble in your account for seven days after purchase.